Table 4.

Stepwise Regression Logistic Analysis Identifying the Role of Each Covariate in Determining a Relevant Growth Deficiency (Delta-SDS <0) While Accounting for the Effect of the Other Covariates

Covariate Relative Risk for Growth Failure 95% CIP Value
Irradiation    .0002  
 No irradiation (36)  1.0  Reference level 
 CRT ± TBI4-150 (50)  6.96  2.11-22.95  
 TBI/TAI/TLI4-151(95)  6.89  2.55-18.57  
Gender  
 Female (69)  1.0 Reference level  
 Male (112)  4.52  1.75-11.66 .0069  
Age (yrs)    .01  
 >11 (60)  1.0 Reference level  
 8.8-11 (61)  2.61  1.73-16.23 
 <8.8 (60)  5.29  0.95-7.19 
Covariate Relative Risk for Growth Failure 95% CIP Value
Irradiation    .0002  
 No irradiation (36)  1.0  Reference level 
 CRT ± TBI4-150 (50)  6.96  2.11-22.95  
 TBI/TAI/TLI4-151(95)  6.89  2.55-18.57  
Gender  
 Female (69)  1.0 Reference level  
 Male (112)  4.52  1.75-11.66 .0069  
Age (yrs)    .01  
 >11 (60)  1.0 Reference level  
 8.8-11 (61)  2.61  1.73-16.23 
 <8.8 (60)  5.29  0.95-7.19 

The estimated effect magnitude is reported as relative risk point estimates (RR) with their 95% confidence intervals (CI).

F4-150

Patients who received CRT during first-line therapy.

F4-151

Patients who did not receive CRT but who had either single or fractionated TBI, TAI, or TLI during pre-BMT conditioning.

Close Modal

or Create an Account

Close Modal
Close Modal